|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S3
|
$600,000
|
$12,000
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S4
|
$75,000
|
$1,500
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-04
|
$1,492,676
|
$74,634
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S1
|
$74,993
|
$3,750
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-04S2
|
$149,680
|
$7,484
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
Virotherapy for pancreatic cancer with wildtype and armed Myxoma viruses
|
5R21CA149869-02
|
$159,319
|
$159,319
|
McFadden, Grant
|
UNIVERSITY OF FLORIDA
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Outpatient Clinic File
|
ZIA CP010126-00580
|
$74,164
|
$3,708
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VEGF and PDGF in angiogenesis and tumor progression
|
5R37CA050286-24
|
$459,245
|
$151,551
|
CHERESH, DAVID
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
Validation of Therapeutic Target Genes in Human Liver Cancer
|
ZIABC011175
|
$268,857
|
$40,329
|
Thorgeirsson, Snorri
|
CCR (NCI)
|
|
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
|
5R01CA154823-02
|
$599,360
|
$599,360
|
KLEIN, ALISON
|
JOHNS HOPKINS UNIVERSITY
|
|
Using mouse models to probe the relationship of oncogenesis to development and o
|
5U01CA105492-09
|
$743,706
|
$245,423
|
HOLLAND, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Using Ketogenic Diets to Enhance Radio-Chemo-Therapy Response: A Phase I Trial
|
5R21CA161182-02
|
$153,590
|
$76,795
|
Spitz, Douglas
|
UNIVERSITY OF IOWA
|
|
Using Claims Data to Evaluate Radiation Therapy Utilization at the End of Life
|
1R21CA164449-01A1
|
$179,850
|
$35,970
|
Guadagnolo, Beverly
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-26S1
|
$74,440
|
$22,332
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-26
|
$1,427,680
|
$428,304
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
2P30CA046592-24
|
$5,694,947
|
$398,646
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S1
|
$49,948
|
$3,496
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S2
|
$74,872
|
$5,241
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-05
|
$1,565,163
|
$15,652
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Underutilization of Surgical Resection in Patients with Pancreatic Cancer
|
5K07CA130983-05
|
$126,552
|
$126,552
|
Riall, Taylor
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Ultrasound enhanced penetration for treatment of pancreatic cancer
|
5R01CA154451-02
|
$526,861
|
$526,861
|
HWANG, JOO
|
UNIVERSITY OF WASHINGTON
|
|
UCSD Cancer Nanotechnology Training Center
|
3R25CA153915-03S1
|
$44,883
|
$11,221
|
MATTREY, ROBERT
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
UCSD Cancer Nanotechnology Training Center
|
5R25CA153915-03
|
$253,913
|
$63,478
|
MATTREY, ROBERT
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
UAB / UMN SPORE in Pancreatic Cancer
|
5P50CA101955-08
|
$2,300,000
|
$2,300,000
|
BUCHSBAUM, DONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Tumor Microenvironment in Cancer Progression
|
ZIABC011332
|
$343,873
|
$17,194
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
|
3P01CA067166-15S1
|
$118,350
|
$59,175
|
Giaccia, Amato
|
STANFORD UNIVERSITY
|
|
Tumor -Targeting Chemotherapeutic Agents
|
5R01CA103314-21
|
$314,565
|
$78,641
|
OJIMA, IWAO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Triptolide Augments Death Receptor Mediated Apoptosis in Pancreatic Cancer
|
1R01CA170946-01
|
$481,186
|
$481,186
|
SALUJA, ASHOK
|
UNIVERSITY OF MINNESOTA
|
|
Transmembrane Proteins Involved in Human Tumor Expansion
|
3R01CA105412-09S1
|
$139,567
|
$139,567
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
Transmembrane Proteins Involved in Human Tumor Expansion
|
5R01CA105412-09
|
$331,909
|
$331,909
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
Translational Research in GI Cancer
|
3P50CA130810-03S1
|
$57,746
|
$33,493
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Translational Research in GI Cancer
|
5P50CA130810-03
|
$2,193,817
|
$1,272,414
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Translational Research in Cancer
|
3P30CA056036-13S1
|
$74,459
|
$2,234
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-13
|
$2,947,311
|
$88,419
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Control by eIF3f in Pancreatic Cancer
|
5R03CA158895-02
|
$75,750
|
$75,750
|
GERNER, EUGENE
|
UNIVERSITY OF ARIZONA
|
|
Transglutaminase Modulated Tumor-Stroma Interaction in Pancreatic Cancer
|
5R21CA152502-02
|
$203,580
|
$203,580
|
Matei, Daniela
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Transforming Growth Factor-Beta Signal Transduction
|
5R37CA034610-30
|
$462,994
|
$462,994
|
MASSAGUE, JOAN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Tissue Factor splicing and pancreatic tumor progression: pilot studies
|
1R21CA160293-01A1
|
$170,738
|
$170,738
|
BOGDANOV, VLADIMIR
|
UNIVERSITY OF CINCINNATI
|
|
Therapeutic targeting of stratifin structure and function
|
5R01CA140582-03
|
$309,964
|
$309,964
|
ZHANG, JIAN-TING
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Theranostic Nano particles for Targeted Treatment of Pancreatic Cancer
|
5U01CA151810-03
|
$391,244
|
$391,244
|
YANG, LILY
|
EMORY UNIVERSITY
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
2U10CA045809-24
|
$1,389,595
|
$125,064
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIASC010373
|
$812,723
|
$16,254
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The role of telomere-related tetraploidization in cancer
|
5R01CA160924-02
|
$351,713
|
$175,857
|
de Lange, Titia
|
ROCKEFELLER UNIVERSITY
|
|
The role of RalA in pancreatic tumorigenesis
|
5K08CA127518-05
|
$130,329
|
$130,329
|
Kendall, Stephan
|
DUKE UNIVERSITY
|
|
The Role of glypican-1 in Pancreatic Cancer Development and Progression
|
5F32CA144579-02
|
$60,482
|
$60,482
|
Whipple, Chery
|
DARTMOUTH COLLEGE
|
|
The role of fibroblasts in the activities of tissue penetrating peptides
|
1R01CA167174-01
|
$407,309
|
$203,655
|
Sugahara, Kazuki
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
The Role of Dendritic Cells in Pancreatic Tumorigenesis
|
5R21CA155649-02
|
$183,788
|
$183,788
|
Miller, George
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The Role of AGR2 in a Murine Model of Pancreatic Adenocarcinoma
|
5R21CA155255-02
|
$221,153
|
$221,153
|
LOWE, ANSON
|
STANFORD UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S3
|
$4,829,857
|
$241,493
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S4
|
$75,000
|
$3,750
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Total relevant funding to Pancreas for this search: $105,352,789
|